NICE (National Institute for Health and Clinical Excellence) set to retain home vs hospital haemodialysis policy - "no new data?":
This article was originally published in Clinica
The UK's National Institute for Health and Clinical Excellence (NICE) is proposing that its current policy on home versus hospital haemodialysis remain unaltered, in view of an apparent lack of new evidence. In a re-run of the search used in the original assessment, NICE has found insufficient additional data to merit carrying out the three-year review, now due, but is asking all original consultees to confirm whether or not any such evidence might exist. In the current October 2002 guidance, NICE recommended that patients in England and Wales with end-stage renal disease who are suitable for home dialysis should be offered the choice between receiving their haemodialysis at home or in a hospital/satellite unit, wherever they live.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.